Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Ecancermedicalscience|January 4, 2014
The impact of the Oncotype DX Recurrence Score on treatment decisions and clinical outcomes in patients with early breast cancer: the Maccabi Healthcare Services experience with a unified testing policyNava Siegelmann-Danieli, Barbara Silverman, Aviad Zick, et al.
The Annals of Pharmacotherapy|December 28, 2006
Brand versus generic alendronate: gastrointestinal effects measured by resource utilizationHillel Halkin, Marina Dushenat, Barbara Silverman, et al.
Journal of Clinical Epidemiology|March 24, 2020
A modified Prevalence Incidence Analysis Model method may improve disease prevalence predictionIlya Novikov, Liraz Olmer, Lital Keinan-Boker, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 21, 2015
Identification of health care needs of long-term breast cancer survivors among Israeli womenLori Mandelzweig, Angela Chetrit, Tova Amitai, et al.
Digestive Diseases and Sciences|January 8, 2025
Modeling and the Use of Surrogate Endpoints: Is This a Valid Approach?Uri Ladabaum, Luuk A van Duuren, Elizabeth E Half, et al.
Breast Cancer Research and Treatment|April 5, 2021
Breast cancer survivors: physical and mental quality of life 10 years following diagnosis, a case-control studyAngela Chetrit, Sivan Ben-Avraham, Lori Mandelzweig, et al.
Parkinsonism & Related Disorders|November 5, 2013
Parkinson's disease patients first treated at age 75 years or older: a comparative studyChava Peretz, Orly Chillag-Talmor, Shai Linn, et al.
Journal of Parkinson'S Disease|August 14, 2013
Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson's disease in a large israeli populationOrly Chillag-Talmor, Nir Giladi, Shai Linn, et al.
Cancer|January 5, 2024
Colorectal cancer screening at age 45 years in Israel: Cost-effectiveness and global implicationsElizabeth E Half, Zohar Levi, Ajitha Mannalithara, et al.
International Clinical Psychopharmacology|September 23, 2017
No apparent association between bipolar disorder and cancer in a large epidemiological study of outpatients in a managed care populationNatan R Kahan, Barbara Silverman, Irena Liphshitz, et al.
Pageof 4